Since curcumin was able to antagonize the repression of miR-34a and miR-34b/c by hypoxia or IL6 exposure, a therapeutic treatment with curcumin may therefore reactivate miR-34 expression in primary CRC and metastases, and thereby suppress progression of CRCs. Here, IL6 is linked to colorectal carcinoma.